Interestingly, two of these three cases were sCJD sub-type Type 3 MV, one of which tested positive for 14-3-3 and T-Tau, whilst the other also tested negative for all CJD CSF biomarkers. This evidence concerns the gene MAPT and Creutzfeldt Jacob disease.